Marion Gasperment joined Sofinnova MD Start in 2019. She manages the MD Start deal flow and focuses on the identification and evaluation of the most promising ideas for incubation. She is also the COO of Ablacare, where she manages the First-in-Human study execution and regulatory approvals in the EU and US. Prior to joining MD Start, Marion was the COO of Cardiologs Technologies, a French medtech start-up leveraging machine learning and expertise in cardiology to provide the most advanced system for arrhythmia screening. Marion holds a Bachelor in Biomedical Science from Imperial College London, and a Master in Management (major in Entrepreneurship) from HEC Paris.